0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Systemic Psoriasis Therapeutics Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-30U5851
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Systemic Psoriasis Therapeutics Market Size Status and Forecast 2021 2027

Global Systemic Psoriasis Therapeutics Market Research Report 2022

Code: QYRE-Auto-30U5851
Report
August 2022
81 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Systemic Psoriasis Therapeutics Market
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.

The global Systemic Psoriasis Therapeutics market size is projected to reach US$ 19660 million by 2028, from US$ 11730 million in 2021, at a CAGR of 7.5% during 2022-2028.

One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Systemic Psoriasis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Systemic Psoriasis Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Systemic Psoriasis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Systemic Psoriasis Therapeutics market.
Global Systemic Psoriasis Therapeutics Scope and Market Size
Systemic Psoriasis Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Systemic Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Biologics
Small Molecules

Segment by Application

Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

AbbVie
Johnson & Johnson
Celgene
Amgen
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Biologics
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Systemic Psoriasis Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Mild Psoriasis
1.3.3 Moderate Psoriasis
1.3.4 Severe Psoriasis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Systemic Psoriasis Therapeutics Market Perspective (2017-2028)
2.2 Systemic Psoriasis Therapeutics Growth Trends by Region
2.2.1 Systemic Psoriasis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Systemic Psoriasis Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Systemic Psoriasis Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Systemic Psoriasis Therapeutics Market Dynamics
2.3.1 Systemic Psoriasis Therapeutics Industry Trends
2.3.2 Systemic Psoriasis Therapeutics Market Drivers
2.3.3 Systemic Psoriasis Therapeutics Market Challenges
2.3.4 Systemic Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Systemic Psoriasis Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Systemic Psoriasis Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Systemic Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Systemic Psoriasis Therapeutics Revenue
3.4 Global Systemic Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Systemic Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Psoriasis Therapeutics Revenue in 2021
3.5 Systemic Psoriasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Systemic Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Systemic Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2023-2028)
5 Systemic Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Systemic Psoriasis Therapeutics Market Size (2017-2028)
6.2 North America Systemic Psoriasis Therapeutics Market Size by Country (2017-2022)
6.3 North America Systemic Psoriasis Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Systemic Psoriasis Therapeutics Market Size (2017-2028)
7.2 Europe Systemic Psoriasis Therapeutics Market Size by Country (2017-2022)
7.3 Europe Systemic Psoriasis Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Psoriasis Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Systemic Psoriasis Therapeutics Market Size (2017-2028)
9.2 Latin America Systemic Psoriasis Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Systemic Psoriasis Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Psoriasis Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Systemic Psoriasis Therapeutics Introduction
11.1.4 AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2017-2022)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2017-2022)
11.2.5 Johnson & Johnson Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Systemic Psoriasis Therapeutics Introduction
11.3.4 Celgene Revenue in Systemic Psoriasis Therapeutics Business (2017-2022)
11.3.5 Celgene Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Systemic Psoriasis Therapeutics Introduction
11.4.4 Amgen Revenue in Systemic Psoriasis Therapeutics Business (2017-2022)
11.4.5 Amgen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Systemic Psoriasis Therapeutics Introduction
11.5.4 Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2017-2022)
11.5.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Biologics
    Table 3. Key Players of Small Molecules
    Table 4. Global Systemic Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Systemic Psoriasis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Systemic Psoriasis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Systemic Psoriasis Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Systemic Psoriasis Therapeutics Market Share by Region (2023-2028)
    Table 10. Systemic Psoriasis Therapeutics Market Trends
    Table 11. Systemic Psoriasis Therapeutics Market Drivers
    Table 12. Systemic Psoriasis Therapeutics Market Challenges
    Table 13. Systemic Psoriasis Therapeutics Market Restraints
    Table 14. Global Systemic Psoriasis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Systemic Psoriasis Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Psoriasis Therapeutics as of 2021)
    Table 17. Ranking of Global Top Systemic Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Systemic Psoriasis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Systemic Psoriasis Therapeutics Product Solution and Service
    Table 21. Date of Enter into Systemic Psoriasis Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Systemic Psoriasis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Systemic Psoriasis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Systemic Psoriasis Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Systemic Psoriasis Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Systemic Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Systemic Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Systemic Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Systemic Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Systemic Psoriasis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Systemic Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Systemic Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Systemic Psoriasis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. AbbVie Company Detail
    Table 42. AbbVie Business Overview
    Table 43. AbbVie Systemic Psoriasis Therapeutics Product
    Table 44. AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. AbbVie Recent Development
    Table 46. Johnson & Johnson Company Detail
    Table 47. Johnson & Johnson Business Overview
    Table 48. Johnson & Johnson Systemic Psoriasis Therapeutics Product
    Table 49. Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Johnson & Johnson Recent Development
    Table 51. Celgene Company Detail
    Table 52. Celgene Business Overview
    Table 53. Celgene Systemic Psoriasis Therapeutics Product
    Table 54. Celgene Revenue in Systemic Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Celgene Recent Development
    Table 56. Amgen Company Detail
    Table 57. Amgen Business Overview
    Table 58. Amgen Systemic Psoriasis Therapeutics Product
    Table 59. Amgen Revenue in Systemic Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Amgen Recent Development
    Table 61. Pfizer Company Detail
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Systemic Psoriasis Therapeutics Product
    Table 64. Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Pfizer Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Systemic Psoriasis Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Biologics Features
    Figure 3. Small Molecules Features
    Figure 4. Global Systemic Psoriasis Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Mild Psoriasis Case Studies
    Figure 6. Moderate Psoriasis Case Studies
    Figure 7. Severe Psoriasis Case Studies
    Figure 8. Systemic Psoriasis Therapeutics Report Years Considered
    Figure 9. Global Systemic Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Systemic Psoriasis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Systemic Psoriasis Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Systemic Psoriasis Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Psoriasis Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2021
    Figure 15. North America Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Systemic Psoriasis Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Systemic Psoriasis Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Systemic Psoriasis Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Systemic Psoriasis Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Systemic Psoriasis Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Systemic Psoriasis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. AbbVie Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2017-2022)
    Figure 44. Johnson & Johnson Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2017-2022)
    Figure 45. Celgene Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2017-2022)
    Figure 46. Amgen Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2017-2022)
    Figure 47. Pfizer Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pruritus Therapeutics Market Size Status and Forecast 2021 2027
Global Pruritus Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-17C2560
Tue Sep 13 00:00:00 UTC 2022

Add to Cart

Global Triamcinolone Acetonide Nasal Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global Triamcinolone Acetonide Nasal Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-2X12323
Wed Sep 07 00:00:00 UTC 2022

Add to Cart

Global Tacrolimus Ointment Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global Tacrolimus Ointment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13E12088
Wed Sep 07 00:00:00 UTC 2022

Add to Cart

Global Eczema Cream Market Research Report 2022
Global Eczema Cream Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-34F11565
Wed Aug 31 00:00:00 UTC 2022

Add to Cart